具有治疗抗体的IL-17A复合体具有明显的尺寸分布,可能有助于临床观察到的免疫性
Dennis Ungan1, Céline Be1, Paulina Baczyk1
1Novartis Biomedical Research, Basel, Switzerland.
mAbs
|October 19, 2025
概括
治疗性抗体可以与向抗原形成大型免疫复合体 (TRIC),可能导致抗药抗体 (ADA) 反应. 抗体结合几何学影响TRIC的大小和组成,影响临床安全性和疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 治疗性单克隆抗体 (mAbs) 对于治疗严重疾病至关重要.
- 抗药抗体 (ADA) 的形成可以限制mAb的有效性和安全性.
- 影响mAb免疫原性的因素,特别是多价抗原,需要进一步研究.
研究的目的:
- 调查表位,副表位和结合几何在与目标相关的免疫复合体 (TRICs) 的形成中的作用.
- 分析由四种临床抗IL-17A抗体形成的TRICs的组成和大小分布.
- 为了将TRIC特征与报告的ADA发病率相关联.
主要方法:
- 由IL-17A和四种抗IL-17A抗体 (secukinumab,ixekizumab,bimekizumab,CJM112) 形成的TRICs的实验性表征.
- 使用生物物理技术分析TRIC的组成和尺寸分布.
- 将TRIC形成模式与临床ADA发病率数据进行比较.
主要成果:
- 这四种抗体都形成了与IL-17A同位体的闭链TRICs.
- 塞库金纽马布主要形成较小的2+2复合体,与较低的ADA率相关.
- 伊克西祖马布,比米祖马布和CJM112形成了较大的复合体 (3+3,4+4) 和非常高分子量TRICs,与较高的ADA发病率相关.
结论:
- 受抗体结合特征影响的TRICs的生物物理性质是免疫性质的关键决定因素.
- 对TRIC的深入分析对于开发更安全,更有效的针对多价抗原的治疗抗体至关重要.
- 了解TRIC的形成可以指导抗体的设计,具有降低免疫原性潜力.
关键词:
分析性评估是一种分析性评估.它们的IL-17A是IL-17A.美国证券交易所 (SEC-MALS)在SV-AUC中.在X射线晶体学.对抗IL-17抗体的抗体.免疫性 免疫性 免疫性质量测光仪的质量测光仪.负染色传递电子显微镜电子显微镜.与目标相关的免疫综合体 (TRIC)更多相关视频
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
9.5K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.7K
相关概念视频
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Antibody Structure
65.3K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.3K
Antibody Structure and Classes
8.2K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
8.2K
